Prevalence of Medication Associated with QTc Prolongation Used Among Critically Ill Patients
Vascular Health and Risk Management · 2024
DOI: 10.2147/vhrm.s438899 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vascular Health and Risk Management, 2024. Verfasst von Ahmad Al-Azayzih und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan. Hauptthemen laut MEDLINE: Long QT Syndrome, Torsades de Pointes. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan.
- Faculty of Pharmacy, Al-Zaytoonah University of Jordan, Amman, Jordan.
- College of Pharmacy, AL Ain University, Abu Dhabi, United Arab Emirates.
- Honorary Associate Lecturer, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
ORCID-Profile: Ahmad Al-Azayzih, Walid Al-Qerem, Suhaib Muflih, Belal A Al-Husein
Zitieren
APA
Al-Azayzih, A., Al-Qerem, W., Al-Azzam, S., Muflih, S., Al-Husein, B. A., Kharaba, Z., Kanaan, R. J., & Rahhal, D. (2024). Prevalence of Medication Associated with QTc Prolongation Used Among Critically Ill Patients. Vascular Health and Risk Management. https://doi.org/10.2147/vhrm.s438899
Vancouver
Al-Azayzih A, Al-Qerem W, Al-Azzam S, Muflih S, Al-Husein BA, Kharaba Z, et al. Prevalence of Medication Associated with QTc Prolongation Used Among Critically Ill Patients. Vascular Health and Risk Management. 2024. doi:10.2147/vhrm.s438899
BibTeX
@article{AlAzayzih2024,
author = {Al-Azayzih, Ahmad and Al-Qerem, Walid and Al-Azzam, Sayer and Muflih, Suhaib and Al-Husein, Belal A and Kharaba, Zelal and Kanaan, Roaa J and Rahhal, Dania},
title = {Prevalence of Medication Associated with QTc Prolongation Used Among Critically Ill Patients},
journal = {Vascular Health and Risk Management},
year = {2024},
doi = {10.2147/vhrm.s438899}
}
EUVIMED